Work

The Kermanshah Acute Coronary Syndrome Registry: Rational and Design

Year: 2019

Type: article

Abstract: Background: The Kermanshah Acute Coronary Syndrome (KACS) Registry, funded by Kermanshah University of Medical Sciences (KUMS).Currently, the patients diagnosed by ST-elevation myocardial infarction (STEMI), are recruited.The registry is aimed to be expanded to include all patients with the diagnosis of ACS including STEMI, in 2022 subject to the success of current project. Methods:In an ongoing cohort study, started July 2016, patients with a diagnosis of STEMI, being ≥18 years old, are recruited.The study proposal has been approved by KUMS' Ethics committee and European Observational Registry Program (EORP).The baseline data include patients' characteristics, presenting symptoms, past medical history, clinical findings, medical procedures and paramedical tests are collected via patient interview and using a check list and questionnaire developed by EORP.The patients will be followed up annually for a minimum of two years.Results: To date 2100 patients with STEMI have been recruited.Data on 220 variables for each participant has been collected.The first year follow up finished July 2018.We are analysing the results.An abstract entitled "Is any sex-specific difference in diabetes adverse effects on the outcomes of patients with myocardial infarction?" was presented at the 20th Asia Pacific Diabetes Conference in Australia (2018).The results gradually will be published. Conclusions:The data in this registry will provide detailed epidemiologic characteristics and a list of risk factors, clinical features, therapeutic approaches provided for patients and their complications.It creates the possibility of investigation of such patients for next two years after their STEMI.

Source: Acta Scientific Medical Sciences

DOI: 10.31080/asms.2019.03.0354